The Met tyrosine kinase receptor in development and cancer

Alessandra Gentile, Livio Trusolino, Paolo M. Comoglio

Research output: Contribution to journalArticle

215 Citations (Scopus)

Abstract

Met is a tyrosine kinase receptor, encoded by an oncogene, whose crucial role has been elucidated during the last two decades. The complex biological program triggered by Met has been dissected and its biological relevance in both physiology and pathology has been proven. Met supports a morphogenetic program, known as invasive growth, taking place both during embryogenesis and adulthood. In tumors Met is often aberrantly activated, giving rise to the pathological counterpart of the invasive growth program: cancer progression towards metastasis. Several approaches have been recently developed to interfere with the tumorigenic and metastatic processes triggered by Met.

Original languageEnglish
Pages (from-to)85-94
Number of pages10
JournalCANCER AND METASTASIS REVIEW
Volume27
Issue number1
DOIs
Publication statusPublished - Mar 2008

Fingerprint

Receptor Protein-Tyrosine Kinases
Growth
Oncogenes
Embryonic Development
Neoplasms
Pathology
Neoplasm Metastasis

Keywords

  • "Invasive growth"
  • HGF
  • Met
  • Metastasis
  • Tyrosine kinase receptor

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

The Met tyrosine kinase receptor in development and cancer. / Gentile, Alessandra; Trusolino, Livio; Comoglio, Paolo M.

In: CANCER AND METASTASIS REVIEW, Vol. 27, No. 1, 03.2008, p. 85-94.

Research output: Contribution to journalArticle

Gentile, Alessandra ; Trusolino, Livio ; Comoglio, Paolo M. / The Met tyrosine kinase receptor in development and cancer. In: CANCER AND METASTASIS REVIEW. 2008 ; Vol. 27, No. 1. pp. 85-94.
@article{0ebbfeeb072f4d4f9f8fe78128093463,
title = "The Met tyrosine kinase receptor in development and cancer",
abstract = "Met is a tyrosine kinase receptor, encoded by an oncogene, whose crucial role has been elucidated during the last two decades. The complex biological program triggered by Met has been dissected and its biological relevance in both physiology and pathology has been proven. Met supports a morphogenetic program, known as invasive growth, taking place both during embryogenesis and adulthood. In tumors Met is often aberrantly activated, giving rise to the pathological counterpart of the invasive growth program: cancer progression towards metastasis. Several approaches have been recently developed to interfere with the tumorigenic and metastatic processes triggered by Met.",
keywords = "{"}Invasive growth{"}, HGF, Met, Metastasis, Tyrosine kinase receptor",
author = "Alessandra Gentile and Livio Trusolino and Comoglio, {Paolo M.}",
year = "2008",
month = "3",
doi = "10.1007/s10555-007-9107-6",
language = "English",
volume = "27",
pages = "85--94",
journal = "Cancer and Metastasis Reviews",
issn = "0167-7659",
publisher = "Springer Netherlands",
number = "1",

}

TY - JOUR

T1 - The Met tyrosine kinase receptor in development and cancer

AU - Gentile, Alessandra

AU - Trusolino, Livio

AU - Comoglio, Paolo M.

PY - 2008/3

Y1 - 2008/3

N2 - Met is a tyrosine kinase receptor, encoded by an oncogene, whose crucial role has been elucidated during the last two decades. The complex biological program triggered by Met has been dissected and its biological relevance in both physiology and pathology has been proven. Met supports a morphogenetic program, known as invasive growth, taking place both during embryogenesis and adulthood. In tumors Met is often aberrantly activated, giving rise to the pathological counterpart of the invasive growth program: cancer progression towards metastasis. Several approaches have been recently developed to interfere with the tumorigenic and metastatic processes triggered by Met.

AB - Met is a tyrosine kinase receptor, encoded by an oncogene, whose crucial role has been elucidated during the last two decades. The complex biological program triggered by Met has been dissected and its biological relevance in both physiology and pathology has been proven. Met supports a morphogenetic program, known as invasive growth, taking place both during embryogenesis and adulthood. In tumors Met is often aberrantly activated, giving rise to the pathological counterpart of the invasive growth program: cancer progression towards metastasis. Several approaches have been recently developed to interfere with the tumorigenic and metastatic processes triggered by Met.

KW - "Invasive growth"

KW - HGF

KW - Met

KW - Metastasis

KW - Tyrosine kinase receptor

UR - http://www.scopus.com/inward/record.url?scp=38549115197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38549115197&partnerID=8YFLogxK

U2 - 10.1007/s10555-007-9107-6

DO - 10.1007/s10555-007-9107-6

M3 - Article

C2 - 18175071

AN - SCOPUS:38549115197

VL - 27

SP - 85

EP - 94

JO - Cancer and Metastasis Reviews

JF - Cancer and Metastasis Reviews

SN - 0167-7659

IS - 1

ER -